Latest Breaking News On - Ionis pharmaceuticals inc - Page 4 : comparemela.com

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36 44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […]

United statesPiper sandlerJoseph baroldiWilliam blairHedge funds weigh in on ionis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyIonis pharmaceuticalsIonis pharmaceuticals stock downMather groupSunbelt securities incWells fargo companySecurities exchange commissionIonis pharmaceuticals company profilePingora partnersIonis pharmaceuticals incGet free report

Reviewing Galecto (NASDAQ:GLTO) & Achaogen (OTCMKTS:AKAOQ)

Galecto (NASDAQ:GLTO – Get Free Report) and Achaogen (OTCMKTS:AKAOQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk Galecto has a beta of 1.26, […]

United statesSouth san franciscoAchaogen incGalecto incThermo fisher scientific incUs bankruptcy courtIonis pharmaceuticals incCrystal biosciences incGet free reportGiven galectoThermo fisher scientificCrystal biosciencesIonis pharmaceuticalsHovione limitedGalecto daily

Alnylam Pharmaceuticals (NASDAQ:ALNY) versus Vaccinex (NASDAQ:VCNX) Critical Contrast

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) and Vaccinex (NASDAQ:VCNX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, profitability, valuation and dividends. Analyst Recommendations This is a summary of recent recommendations […]

United statesNew yorkUnited kingdomEmory universityAlnylam pharmaceuticalsAlnylam pharmaceuticals incPeptidream incHuntington study groupCatalent pharma solutionsBiotech coSurface oncology incVir biotechnology incVaccinex incResearch institute incDicerna pharmaceuticals incRegeneron pharmaceuticals inc

Comparing Alnylam Pharmaceuticals (NASDAQ:ALNY) and TFF Pharmaceuticals (NASDAQ:TFFP)

Comparing Alnylam Pharmaceuticals (NASDAQ:ALNY) and TFF Pharmaceuticals (NASDAQ:TFFP)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Fort worthUnited statesUnited kingdomVir biotechnology incRegeneron pharmaceuticals incAlnylam pharmaceuticals incNational institute of environmental health sciencesDicerna pharmaceuticals incAlnylam pharmaceuticalsPharmaceuticals incPeptidream incUniversity of texas at austinAugmenta bioworks incNews ratings for alnylam pharmaceuticals dailyIonis pharmaceuticals incGet free report

Ionis, Biogen Down on Ending Development of ALS Drug - Heron Therapeutics (NASDAQ:HRTX), Biogen (NASDAQ:BIIB)

Ionis, Biogen Down on Ending Development of ALS Drug - Heron Therapeutics (NASDAQ:HRTX), Biogen (NASDAQ:BIIB)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Heron therapeuticsEarnings of ligand pharmaceuticalsLigand pharmaceuticalsBiogen incAngelman syndrome foundationIonis pharmaceuticals incIonis pharmaceuticalsAngelman syndromeZacks rankLigand pharmaceuticalHeron therapeutic